The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.

A functional mooring sequence, known to be required for apolipoprotein B (apoB) mRNA editing, exists in the mRNA encoding the neurofibromatosis type I (NF1) tumor suppressor. Editing of NF1 mRNA modifies cytidine in an arginine codon (CGA) at nucleotide 2914 to a uridine (UGA), creating an in frame translation stop codon. NF1 editing occurs in normal tissue but was several-fold higher in tumors. In vitro editing and transfection assays demonstrated that apoB and NF1 RNA editing will take place in both neural tumor and hepatoma cells. Unlike apoB, NF1 editing did not demonstrate dependence on rate-limiting quantities of APOBEC-1 (the apoB editing catalytic subunit) suggesting that different trans-acting factors may be involved in the two editing processes.

[1]  J. Scott,et al.  Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells. , 1989, The Journal of biological chemistry.

[2]  N. Navaratnam,et al.  Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Nishikura,et al.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Anant,et al.  apobec-1, the Catalytic Subunit of the Mammalian Apolipoprotein B mRNA Editing Enzyme, Is a Novel RNA-binding Protein (*) , 1995, The Journal of Biological Chemistry.

[5]  N. Navaratnam,et al.  Sequence requirements for the editing of apolipoprotein B mRNA. , 1991, The Journal of biological chemistry.

[6]  L. Maquat,et al.  Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping , 1994, Molecular and cellular biology.

[7]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[8]  H. C. Smith,et al.  Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins. , 1993, The Journal of biological chemistry.

[9]  T. Innerarity,et al.  Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. , 1994, The Journal of biological chemistry.

[10]  M. Higuchi,et al.  Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase , 1995, Molecular and cellular biology.

[11]  J. Scott,et al.  Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. , 1988, The Journal of biological chemistry.

[12]  K. Kitagawa,et al.  Developmental and age-related changes in apolipoprotein B mRNA editing in mice. , 1992, Journal of lipid research.

[13]  S. Huson,et al.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. , 1989, Journal of medical genetics.

[14]  D. Driscoll,et al.  Expression and characterization of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. , 1994, The Journal of biological chemistry.

[15]  S. Sukumar,et al.  RNA editing in the Wilms' tumor susceptibility gene, WT1. , 1994, Genes & development.

[16]  K. Macdermot,et al.  Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion. , 1995, Nucleic acids research.

[17]  S. Heinemann,et al.  Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Rowley,et al.  Molecular genetic analysis of tumors in von recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17 , 1989, Genes, chromosomes & cancer.

[19]  S. Pääbo,et al.  Editing of a tRNA anticodon in marsupial mitochondria changes its codon recognition. , 1993, Nucleic acids research.

[20]  A. Paller.  Neurofibromatosis: Phenotype, Natural History, and Pathogenesis , 1993 .

[21]  H. C. Smith,et al.  Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro. , 1992, Nucleic acids research.

[22]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[23]  N. Copeland,et al.  Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway , 1990, Nature.

[24]  P. Lau,et al.  A 40 kilodalton rat liver nuclear protein binds specifically to apolipoprotein B mRNA around the RNA editing site. , 1990, Nucleic acids research.

[25]  P. Seeburg,et al.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels , 1991, Cell.

[26]  H. C. Smith,et al.  Apolipoprotein B mRNA sequences 3' of the editing site are necessary and sufficient for editing and editosome assembly. , 1991, Nucleic acids research.

[27]  J. Scott,et al.  Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1. , 1995, RNA.

[28]  C. Burant,et al.  Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. , 1994, The Journal of biological chemistry.

[29]  T. Sekiya,et al.  Two nucleotides next to the anticodon of cytoplasmic rat tRNA(Asp) are likely generated by RNA editing. , 1992, Nucleic acids research.

[30]  L. Maquat,et al.  Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA. , 1993, Molecular and cellular biology.

[31]  B. Ganem.  RNA world , 1987, Nature.

[32]  H. C. Smith.  Apolipoprotein B mRNA editing: the sequence to the event. , 1993, Seminars in cell biology.

[33]  H. C. Smith,et al.  Only cytidines 5' of the apolipoprotein B mRNA mooring sequence are edited. , 1994, Biochimica et biophysica acta.

[34]  J. Ross,et al.  The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3' untranslated regions and role of ribosome translocation , 1994, Molecular and cellular biology.

[35]  P. Seeburg,et al.  RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency , 1993, Cell.

[36]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[37]  C. Burant,et al.  Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.

[38]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[39]  D. Cosman.  Control of messenger RNA stability. , 1987, Immunology today.

[40]  P. Seeburg,et al.  Editing of α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor GluR-B Pre-mRNA in Vitro Reveals Site-selective Adenosine to Inosine Conversion(*) , 1995, The Journal of Biological Chemistry.

[41]  D. Driscoll,et al.  Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA , 1993, Molecular and cellular biology.

[42]  J. Taylor,et al.  Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. , 1989, The Journal of biological chemistry.

[43]  L. Maquat,et al.  Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life , 1994, Molecular and cellular biology.

[44]  N. Davidson,et al.  REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. , 1994, Journal of lipid research.

[45]  J. Morrison,et al.  The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. , 1993, The Journal of biological chemistry.

[46]  D. Easton,et al.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. , 1993, American journal of human genetics.

[47]  J. Belasco,et al.  Control of messenger RNA stability. , 1993 .

[48]  R. Emeson,et al.  Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine , 1995, Science.

[49]  Margaret Robertson,et al.  The neurofibromatosis type 1 gene encodes a protein related to GAP , 1990, Cell.

[50]  S. Peltz,et al.  mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor. , 1993, Genes & development.

[51]  H. Saya,et al.  Differential splicing of the neurofibromatosis type-1 gene in the rat - splice variants homologous with the human are expressed in rat-cells. , 1992, International Journal of Oncology.

[52]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Schull,et al.  A clinical, pathological, and genetic study of multiple neurofibromatosis , 1956 .

[54]  James Scott,et al.  Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site , 1995, Cell.